7 completed, 2 suspended. 6 Phase 2, 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Completed 4, Suspended 2 |
| Phase 1 | 3 | Completed 3 |
Follow capravirine: new trials by email Literature Review of capravirine trials Research Report on capravirine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Four-Drug Combination Treatment in Hiv-Infected Subjects Failing Therapy With Antiretroviral Regimens capravirine, Kaletra, 2 NRTIs - HIV Infections | Phase 2 | Completed | Pfizer | 300 | 2003-01-01 | 2007-10-10 |
| Capravirine (AG1549) in Combination With Viracept and Two NRTIs in HIV Infected Patients Who Failed an Initial NNRTI Containing Regimen Capravirine - Human Immunodeficiency Virus | Phase 2 | Completed | Pfizer | 179 | 2002-08-01 | 2011-05-10 |
| Capravirine to Treat Children With HIV Infection Capravirine - HIV Infection | Phase 1 | Completed | National Cancer Institute (NCI) | 96 | 2000-11-01 | 2006-07-11 |
| Safety and Anti-HIV Activity of Capravirine Alone and in Combination With Other Anti-HIV Drugs Capravirine - Healthy, HIV Infection | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 46 | 2000-05-01 | 2008-03-04 |
| A Study of Capravirine Plus VIRACEPT Plus Two Nucleoside Reverse Transcriptase Inhibitors in HIV-Infected Patients Who Failed Previous Anti-HIV Treatments Capravirine, Nelfinavir mesylate - HIV Infections | Phase 2 | Completed | Agouron Pharmaceuticals | 350 | 2000-02-01 | 2005-06-24 |
| Combination Treatment Using Capravirine (AG1549), Nelfinavir, and Two Nucleoside Reverse Transcriptase Inhibitors in HIV Patients Who Failed Initial Combination Therapy Capravirine, Nelfinavir mesylate - HIV Infections | Phase 2 | Completed | Agouron Pharmaceuticals | 75 | 2000-01-01 | 2005-06-24 |
| Safety and Effectiveness of a New Anti-HIV Drug (AG1549) in Combination With Other Anti-HIV Drugs in HIV-Infected Patients Lamivudine/Zidovudine, Capravirine, Nelfinavir mesylate - HIV Infections | Phase 2 | Suspended | Agouron Pharmaceuticals | 30 | 1999-11-01 | 2005-06-24 |
| Effectiveness of a New Anti-HIV Drug (AG1549) Plus Viracept (Nelfinavir) Plus Combivir (Zidovudine/Lamivudine) in HIV-Infected Patients Lamivudine/Zidovudine, Capravirine, Nelfinavir mesylate - HIV Infections | Phase 2 | Suspended | Agouron Pharmaceuticals | 350 | 1999-08-01 | 2005-06-24 |
| Phase I Trial of S-1153 in Patients With HIV Infection Capravirine - HIV Infections | Phase 1 | Completed | Lexigen Pharmaceuticals | 40 | 2005-06-24 |
HIV Infections (9) · Acquired Immunodeficiency Syndrome (1) · Disease Progression (1)
Agouron Pharmaceuticals (4) · Pfizer (2) · Lexigen Pharmaceuticals (1) · National Cancer Institute (NCI) (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1)
United States (8) · Dominican Republic (2) · Puerto Rico (2) · Canada (1) · France (1) · Germany (1) · Italy (1) · South Africa (1) · Spain (1)